36C26318R0477-010.xlsx
XLSX spreadsheet 30 KB Posted
- Attached to
- Pathology Services Des Moines POP: PO#
- Solicitation number
- 36C26318R0477
About this file
36C26318R0477 D.9 - Price Schedule.xlsx
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C26318R0477-0002000.docx | DOCX document | |
| 36C26318R0477-0001000.docx | DOCX document | |
| 36C26318R0477-005.pdf | ||
| 36C26318R0477-002.pdf | ||
| 36C26318R0477-006.pdf | ||
| 36C26318R0477-001.pdf | ||
| 36C26318R0477-008.pdf | ||
| 36C26318R0477-007.pdf | ||
| 36C26318R0477-009.pdf | ||
| 36C26318R0477-000.docx | DOCX document | |
| 36C26318R0477-003.pdf | ||
| 36C26318R0477-004.pdf |
Show all 12
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Pathology Price Schedule
| Pathology and Laboratory Testing Services Price Schedule | |||||||||||||||||||
| 103% | 103% | 103% | 103% | ||||||||||||||||
| Ordering Period December 1, 2018 - November 30, 2019 | Ordering Period December 1, 2019 - November 30, 2020 | Ordering Period December 1, 2020 - November 30, 2021 | Ordering Period December 1, 2021 - November 30, 2022 | Ordering Period December 1, 2022 - November 30, 2023 | Minimum | Maximum | |||||||||||||
| CLIN | TESTING PROCEDURE/OFF SITE | CPT | Est Qty | CMS Rate | Extended Amount | Est Qty | CMS Rate | Extended Amount | Est Qty | CMS Rate | Extended Amount | Est Qty | CMS Rate | Extended Amount | Est Qty | CMS Rate | Extended Amount | Minimum | Maximum |
| 0001 | CALR GENE COM VARIANTS | 81219 | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 0 | 24 |
| 0002 | EGFR Gene Com Variants | 81235 | 4 | $ | $ | 4 | $ | $ | 4 | $ | $ | 4 | $ | $ | 5 | $ | $ | 1 | 32 |
| 0003 | JAK2 Gene | 81270 | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 1 | 24 |
| 0004 | PML/RARalpha | 81315 | 2 | $ | $ | 2 | $ | $ | 2 | $ | $ | 2 | $ | $ | 2 | $ | $ | 1 | 16 |
| 0005 | T Cell receptor rearrangement | 81342 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0006 | Unlisted molecular pathology procedure | 81479 | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 1 | 24 |
| 0007 | Bone Marrow Interpretation | 85097 | 41 | $ | $ | 42 | $ | $ | 43 | $ | $ | 45 | $ | $ | 46 | $ | $ | 0 | 327 |
| 0008 | Cyto Non-Gyn Liquid Prep | 88112-TC | 77 | $ | $ | 79 | $ | $ | 82 | $ | $ | 84 | $ | $ | 87 | $ | $ | 1 | 613 |
| 0009 | Fine Needle Aspirate | 88173-TC | 29 | $ | $ | 30 | $ | $ | 31 | $ | $ | 32 | $ | $ | 33 | $ | $ | 1 | 231 |
| 0010 | Flow Cytometry first antibody | 88184-TC | 19 | $ | $ | 20 | $ | $ | 20 | $ | $ | 21 | $ | $ | 21 | $ | $ | 1 | 151 |
| 0011 | Flow cytometry Additional antibodies | 88185-TC | 225 | $ | $ | 232 | $ | $ | 239 | $ | $ | 246 | $ | $ | 253 | $ | $ | 1 | 1792 |
| 0012 | Tissue culture for neoplastic disorders;bone marrow | 88237-TC | 39 | $ | $ | 40 | $ | $ | 41 | $ | $ | 43 | $ | $ | 44 | $ | $ | 0 | 311 |
| 0013 | Solid tumor | 88239-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0014 | Chromosome analysis count 5 cells, 1 karyotype with banding | 88261-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0015 | Chromosome analysis count 15-20 cells, 2 karyotype with banding | 88262-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0016 | Chromosome analysis count 45 cells for masaicism,, 2 karyotype with banding | 88263-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0017 | Chromosome analysis count 20-25 cells | 88264-TC | 33 | $ | $ | 34 | $ | $ | 35 | $ | $ | 36 | $ | $ | 37 | $ | $ | 0 | 263 |
| 0018 | Cytogenetics DNA Probe | 88271 | 4 | $ | $ | 4 | $ | $ | 4 | $ | $ | 4 | $ | $ | 5 | $ | $ | 1 | 32 |
| 0019 | Tzank Prep | 88273-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0020 | Cytogenetics 100-300 | 88275 | 2 | $ | $ | 2 | $ | $ | 2 | $ | $ | 2 | $ | $ | 2 | $ | $ | 1 | 16 |
| 0021 | Chormosome Karyotype Study | 88280 | 5 | $ | $ | 5 | $ | $ | 5 | $ | $ | 5 | $ | $ | 6 | $ | $ | 0 | 40 |
| 0022 | Chromosome analysis additional cells counted, each study. | 88285-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0023 | Cyto/Molecular Report | 88291 | 36 | $ | $ | 37 | $ | $ | 38 | $ | $ | 39 | $ | $ | 41 | $ | $ | 0 | 287 |
| 0024 | Level IV Surgical Pathology gross & Microscopic (Bone Marrow) | 88305-TC | 95 | $ | $ | 98 | $ | $ | 101 | $ | $ | 104 | $ | $ | 107 | $ | $ | 0 | 757 |
| 0025 | Decalcification | 88311-TC | 40 | $ | $ | 41 | $ | $ | 42 | $ | $ | 44 | $ | $ | 45 | $ | $ | 0 | 319 |
| 0026 | Special Stain Group 1 | 88312-TC | 176 | $ | $ | 181 | $ | $ | 187 | $ | $ | 192 | $ | $ | 198 | $ | $ | 0 | 1402 |
| 0027 | Special Stain Group 2 | 88313-TC | 127 | $ | $ | 131 | $ | $ | 135 | $ | $ | 139 | $ | $ | 143 | $ | $ | 0 | 1011 |
| 0028 | Enzyme Histochemistry | 88319-TC | 37 | $ | $ | 38 | $ | $ | 39 | $ | $ | 40 | $ | $ | 42 | $ | $ | 1 | 295 |
| 0029 | Consultation (slides prepared elsewhere)* | 88321 | 5 | $ | $ | 5 | $ | $ | 5 | $ | $ | 5 | $ | $ | 6 | $ | $ | 1 | 40 |
| 0030 | Consultation (requires preparation of slides)* | 88323 | 19 | $ | $ | 20 | $ | $ | 20 | $ | $ | 21 | $ | $ | 21 | $ | $ | 1 | 151 |
| 0031 | Consultation, comprehensive (requires review of records and specimens* | 88325 | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 3 | $ | $ | 1 | 24 |
| 0032 | Immunohistochemistry, per specimen, each additional single antibody stain | 88341 | 91 | $ | $ | 94 | $ | $ | 97 | $ | $ | 99 | $ | $ | 102 | $ | $ | 1 | 725 |
| 0033 | Immuno-Histochemistry | 88364 | 917 | $ | $ | 945 | $ | $ | 973 | $ | $ | 1002 | $ | $ | 1032 | $ | $ | 0 | 7303 |
| 0034 | Immunohistochemistry, per specimen, each multiplex stain | 88344 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0035 | Immunofluorescent Study (each antibody | 88346-TC | 27 | $ | $ | 28 | $ | $ | 29 | $ | $ | 30 | $ | $ | 30 | $ | $ | 1 | 215 |
| 0036 | Electron Microscopy | 88348-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0037 | Immunofluorescence Additional stains | 88350 | 53 | $ | $ | 55 | $ | $ | 56 | $ | $ | 58 | $ | $ | 60 | $ | $ | 1 | 422 |
| 0038 | Tumor Immunohistochem/Manual | 88360 | 7 | $ | $ | 7 | $ | $ | 7 | $ | $ | 8 | $ | $ | 8 | $ | $ | 1 | 56 |
| 0039 | Immunohistochemistry with computer assisted tech | 88361-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0040 | In situ hybridization, per specimen, each additional probe stain | 88364 | 8 | $ | $ | 8 | $ | $ | 8 | $ | $ | 9 | $ | $ | 9 | $ | $ | 0 | 64 |
| 0041 | In situ Hybridization | 88365-TC | 28 | $ | $ | 29 | $ | $ | 30 | $ | $ | 31 | $ | $ | 32 | $ | $ | 0 | 223 |
| 0042 | In situ hybridization, per specimen, each multiplex probe stain | 88366 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0043 | MDS in situ TC | 88367-TC | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0044 | Morphometric analysis in situ hybridization, manual, per specimen | 88368 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0045 | Morphometric analysis in situ hybridization, manual, per specimen, each additional single probe stain | 88369 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0046 | Morphometric analysis, in situ hybridization each additional | 88373 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0047 | Morphometric analysis, in situ hybridization | 88374 | 20 | $ | $ | 21 | $ | $ | 21 | $ | $ | 22 | $ | $ | 23 | $ | $ | 1 | 159 |
| 0048 | Morphometric analysis in situ hybridization, manual, per specimen, each multiplex stain | 88377 | 4 | $ | $ | 4 | $ | $ | 4 | $ | $ | 4 | $ | $ | 5 | $ | $ | 1 | 32 |
| 0049 | Surgical Pathology, gross and micro, prostate needle biopsy, any method | G0416 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0050 | First Immuno Stain | G0461 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| 0051 | Subsequent immune stains | G0462 | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 1 | $ | $ | 0 | 8 |
| Sub-total | $ | Sub-total | $ | Sub-total | $ | Sub-total | $ | Sub-total | $ |
| Description | Quantity | Hours | Quantity | Hours | Quantity | Hours | Quantity | Hours | Quantity | Hours | ||||||||
| 0052 | Pathology Assistant | 260 | $ | $ | 260 | $ | $ | 260 | $ | $ | 260 | $ | $ | 260 | $ | $ | 1 | 1,950 |
| 0053 | Pathologist On-Site | 598 | $ | $ | 598 | $ | $ | 598 | $ | $ | 598 | $ | $ | 598 | $ | $ | 1 | 4,485 |
| 0054 | Pathologist Off-site Consulation | 260 | $ | $ | 260 | $ | $ | 260 | $ | $ | 260 | $ | $ | 260 | $ | $ | 1 | 1,950 |
| 0055 | Pathologist Administrative Meetings | 12 | $ | $ | 12 | $ | $ | 12 | $ | $ | 12 | $ | $ | 12 | $ | $ | 1 | 90 |
| 0056 | Pathologist Call-Back | 160 | $ | $ | 160 | $ | $ | 160 | $ | $ | 160 | $ | $ | 160 | $ | $ | 1 | 1,200 |
0057 On-call Pathologist 8760 $ $ 8760 $ $ 8760 $ $ 8760 $ $ 8760 $ $ 1 65,700
Total $ $ $ $ $
GRAND TOTAL: $__________________________
For Official Use Only (FOUO)
File details come from the government source that posted it.